Skip to main content
Veterinary Medicines

Hapadex 50 mg/ml - Suspension zum Eingeben für Schafe

Not authorised
  • Netobimin

Product identification

Medicine name:
Hapadex 50 mg/ml - Suspension zum Eingeben für Schafe
Active substance:
  • Netobimin
Target species:
  • Sheep
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Netobimin
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Sheep
      • Meat and offal
        6
        day
      • Milk
        5
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC06
Authorisation status:
  • Surrendered
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet Ges.m.b.H.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Trirx Segre
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-00155
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 22/10/2020
Updated on: 3/05/2024

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 21/06/2013
Updated on: 3/05/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 21/06/2013
Updated on: 3/05/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."